Parcopa Dosage
Recommended Adult Dosing
Dosage forms: TAB: 10 mg/100 mg, 25 mg/100 mg, 25 mg/250 mg; ER TAB: 25 mg/100 mg, 50 mg/200 mg; ODT: 10 mg/100 mg, 25 mg/100 mg, 25 mg/250 mg
Parkinsonism
- [immediate-release form]
- Dose: individualize dose PO tid-qid; Start: 10 mg/100 mg PO tid-qid or 25 mg/100 mg PO tid, may incr. by 1 tab/day q1-2 days; Max: 200 mg/2000 mg/day; Info: 70-100 mg/day carbidopa needed to saturate periph. dopa decarboxylase and minimize adverse effects; taper dose gradually to D/C
- [extended-release form]
- Dose: individualize dose ER PO bid-tid; Start: 50 mg/200 mg ER PO bid, separate doses by >6h; may incr. by 0.5-1 tab/day q3 days; Max: 600 mg/2400 mg/day ER; Info: start 10% higher levodopa dose if switching from reg. release product; give maint. bid-tid doses q4-8h while awake; ER tab may be split, but do not crush/chew; taper dose gradually to D/C
Sleep-related eating disorder
- [25 mg/100 mg PO qhs]
Restless legs syndrome
- [immediate-release form]
- Dose: 25 mg/100 mg PO qhs prn; Max: 50 mg/200 mg/day; Info: for intermittent sx; may start 12.5 mg/50 mg PO qhs x1-2 days; taper dose gradually to D/C
- [extended-release form]
- Dose: 25 mg/100 mg ER PO qhs prn; Max: 50 mg/200 mg/day ER; Info: for intermittent sx; ER tab may be split, but do not crush/chew; taper dose gradually to D/C
Renal dosing
- [adjust dose amount]
- CrCl <50: decr. usual dose by up to 50%
- HD: decr. usual dose by up to 50%, on dialysis days admin. after dialysis; no supplement; PD: decr. usual dose by up to 50%; no supplement
Hepatic dosing
- [not defined]
- hepatic impairment: caution advised
SRC: NLM .